1. A prospective Phase II study to examine the relationship between quality of life and adverse events of first‐line chemotherapy plus cetuximab in patients with KRAS wild‐type unresectable metastatic colorectal cancer: QUACK trial. (26th July 2018) Authors: Iwamoto, Shigeyoshi; Ooki, Akira; Morita, Satoshi; Hara, Hiroki; Tanioka, Hiroaki; Satake, Hironaga; Kataoka, Masato; Kotaka, Masahito; Kagawa, Yoshinori; Nakamura, Masato; Shingai, Tatsushi; Ishikawa, Masashi; Miyake, Yasuhiro; Sudo, Takeshi; Hashiguchi, Yojiro; Yabuno, Taichi; Sakamoto, Junichi... Journal: Cancer medicine Issue: Volume 7:Number 9(2018:Sep.) Page Start: 4217 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Arsenic promotes the COX2/PGE2–SOX2 axis to increase the malignant stemness properties of urothelial cells. Issue 1 (14th February 2018) Authors: Ooki, Akira; Begum, Asma; Marchionni, Luigi; VandenBussche, Christopher J.; Mao, Shifeng; Kates, Max; Hoque, Mohammad Obaidul Journal: International journal of cancer Issue: Volume 143:Issue 1(2018) Page Start: 113 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Combined microsatellite instability and BRAF gene status as biomarkers for adjuvant chemotherapy in stage III colorectal cancer. Issue 8 (22nd August 2014) Authors: Ooki, Akira; Akagi, Kiwamu; Yatsuoka, Toshimasa; Asayama, Masako; Hara, Hiroki; Takahashi, Akemi; Kakuta, Miho; Nishimura, Yoji; Yamaguchi, Kensei Journal: Journal of surgical oncology Issue: Volume 110:Issue 8(2014:Dec. 15) Page Start: 982 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Correlation between circulating tumor DNA and carcinoembryonic antigen levels in patients with metastatic colorectal cancer. (24th November 2021) Authors: Osumi, Hiroki; Shinozaki, Eiji; Ooki, Akira; Shimozaki, Keitaro; Kamiimabeppu, Daisaku; Nakayama, Izuma; Wakatsuki, Takeru; Ogura, Mariko; Takahari, Daisuke; Chin, Keisho; Yamaguchi, Kensei Journal: Cancer medicine Issue: Volume 10:Number 24(2021) Page Start: 8820 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Disagreement between patient‐ and physician‐reported outcomes on symptomatic adverse events as poor prognosis in patients treated with first‐line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: Results of Phase II QUACK trial. (21st November 2020) Authors: Ooki, Akira; Morita, Satoshi; Tsuji, Akihito; Iwamoto, Shigeyoshi; Hara, Hiroki; Tanioka, Hiroaki; Satake, Hironaga; Kataoka, Masato; Kotaka, Masahito; Kagawa, Yoshinori; Nakamura, Masato; Shingai, Tatsushi; Ishikawa, Masashi; Miyake, Yasuhiro; Suto, Takeshi; Hashiguchi, Yojiro; Yabuno, Taichi; A... Journal: Cancer medicine Issue: Volume 9:Number 24(2020) Page Start: 9419 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Early hypertension and neutropenia are predictors of treatment efficacy in metastatic colorectal cancer patients administered FOLFIRI and vascular endothelial growth factor inhibitors as second‐line chemotherapy. (21st December 2020) Authors: Osumi, Hiroki; Shinozaki, Eiji; Ooki, Akira; Wakatsuki, Takeru; Kamiimabeppu, Daisaku; Sato, Taro; Nakayama, Izuma; Ogura, Mariko; Takahari, Daisuke; Chin, Keisho; Yamaguchi, Kensei Journal: Cancer medicine Issue: Volume 10:Number 2(2021) Page Start: 615 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Epigenetically regulated PAX6 drives cancer cells toward a stem-like state via GLI-SOX2 signaling axis in lung adenocarcinoma. Issue 45 (8th November 2018) Authors: Ooki, Akira; Dinalankara, Wikum; Marchionni, Luigi; Tsay, Jun-Chieh; Goparaju, Chandra; Maleki, Zahra; Rom, William; Pass, Harvey; Hoque, Mohammad Journal: Oncogene Issue: Volume 37:Issue 45(2018) Page Start: 5967 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Inverse effect of mucinous component on survival in stage III colorectal cancer. Issue 7 (11th August 2014) Authors: Ooki, Akira; Akagi, Kiwamu; Yatsuoka, Toshimasa; Asayama, Masako; Hara, Hiroki; Yamamoto, Gou; Nishimura, Yoji; Yamaguchi, Kensei Journal: Journal of surgical oncology Issue: Volume 110:Issue 7(2014:Dec. 01) Page Start: 851 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Non‐V600E BRAF mutations and EGFR signaling pathway in colorectal cancer. Issue 9 (7th May 2019) Authors: Osumi, Hiroki; Shinozaki, Eiji; Wakatsuki, Takeru; Suenaga, Mitsukuni; Ichimura, Takashi; Ogura, Mariko; Takahari, Daisuke; Ooki, Akira; Suzuki, Takeshi; Ota, Yumiko; Nakayama, Izuma; Chin, Keisho; Miki, Yoshio; Yamaguchi, Kensei Journal: International journal of cancer Issue: Volume 145:Issue 9(2019) Page Start: 2488 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Patient‐reported symptom burden as a prognostic factor in treatment with first‐line cetuximab plus chemotherapy for unresectable metastatic colorectal cancer: Results of Phase II QUACK trial. (21st January 2020) Authors: Ooki, Akira; Morita, Satoshi; Iwamoto, Shigeyoshi; Hara, Hiroki; Tanioka, Hiroaki; Satake, Hironaga; Kataoka, Masato; Kotaka, Masahito; Kagawa, Yoshinori; Nakamura, Masato; Shingai, Tatsushi; Ishikawa, Masashi; Miyake, Yasuhiro; Suto, Takeshi; Hashiguchi, Yojiro; Yabuno, Taichi; Sakamoto, Junichi... Journal: Cancer medicine Issue: Volume 9:Number 5(2020) Page Start: 1779 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗